CLOVER GROUP PRACTICE — All Prescriptions & Medications — Page 12
Practice Code: C88069 | SHEFFIELD, S9 4QH
Showing results 551-600 of 708
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 23 | 968 | £256 | -21.7% ▼ | |
| Phosphates (Rectal) | 22 | 746 | £8.8K | +80.0% ▲ |
| Alimemazine tartrate | 22 | 2,084 | £3.7K | +70.2% ▲ |
| Colistimethate sodium | 22 | 1,440 | £2.6K | +94.6% ▲ |
| Indometacin | 22 | 1,208 | £75 | +39.8% ▲ |
| Brinzolamide/brimonidine | 22 | 215 | £377 | -35.9% ▼ |
| Xylometazoline hydrochloride | 22 | 400 | £94 | +283.2% ▲ |
| Eflornithine monohydrate chloride | 22 | 1,320 | £1.2K | +213.1% ▲ |
| 22 | 1,170 | £1.0K | +124.6% ▲ | |
| Ethosuximide | 21 | 7,600 | £6.6K | +42.4% ▲ |
| RtS 2-2.4 kcal/ml m/sk higher protein,higher energy(0913011) | 21 | 255.2K | £2.9K | -52.0% ▼ |
| Prednisolone sodium phosphate | 21 | 280 | £116 | +64.6% ▲ |
| Aciclovir | 21 | 62 | £56 | +70.3% ▲ |
| 21 | 3,104 | £151 | +62.8% ▲ | |
| 21 | 45 | £273 | -41.3% ▼ | |
| 21 | 3,810 | £2.6K | +88.8% ▲ | |
| 21 | 770 | £4.0K | -5.9% ▼ | |
| Nicotine | 20 | 1,411 | £1.6K | -64.6% ▼ |
| Valaciclovir | 20 | 1,880 | £2.3K | +42.3% ▲ |
| 20 | 4,260 | £85 | +560.6% ▲ | |
| Meloxicam | 19 | 600 | £18 | -71.3% ▼ |
| Methyl salicylate | 19 | 1,330 | £85 | +124.6% ▲ |
| 19 | 2,042 | £3.0K | +3.2% ▲ | |
| 19 | 62 | £1.0K | +37.6% ▲ | |
| 19 | 155 | £344 | -21.4% ▼ | |
| 19 | 960 | £3.4K | -58.0% ▼ | |
| Captopril | 18 | 1,326 | £566 | +24.4% ▲ |
| Tibolone | 18 | 728 | £65 | -41.2% ▼ |
| Tube feed 1 kcal/ml with fibre (0914021) | 18 | 264.0K | £6.1K | +93.8% ▲ |
| Budesonide | 18 | 18 | £179 | +15.7% ▲ |
| 18 | 49 | £56 | -42.2% ▼ | |
| Guanfacine | 17 | 560 | £1.2K | -33.8% ▼ |
| Deflazacort | 17 | 1,350 | £339 | +92.7% ▲ |
| Etonogestrel | 17 | 17 | £1.4K | -41.2% ▼ |
| Alprostadil | 17 | 98 | £1.1K | -0.6% vs avg |
| RtS 3.3 - 4 kcal/ml energy with protein liquid (0913141) | 17 | 46.9K | £1.5K | -36.0% ▼ |
| Tablets OTC glucose for diabetic hypo treatment (0913541) | 17 | 360 | £28 | +13.1% ▲ |
| Tube feed 1 kcal/ml peptide based (0914032) | 17 | 288.0K | £5.1K | +90.5% ▲ |
| Other barrier preparations | 17 | 720 | £76 | +187.3% ▲ |
| Ketoconazole | 17 | 630 | £85 | +70.9% ▲ |
| 17 | 820 | £4.3K | +169.3% ▲ | |
| 17 | 90 | £267 | +112.7% ▲ | |
| 17 | 62 | £477 | +6.3% ▲ | |
| Sucralfate | 16 | 2,232 | £2.8K | +90.5% ▲ |
| Doxepin | 16 | 686 | £2.4K | +23.1% ▲ |
| Doxylamine succinate/pyridoxine hydrochloride | 16 | 740 | £1.1K | +45.0% ▲ |
| Testosterone esters | 16 | 31 | £72 | +8.5% ▲ |
| Magnesium glycerophosphate | 16 | 1,672 | £722 | +16.4% ▲ |
| Tacalcitol | 16 | 750 | £279 | +267.3% ▲ |
| Sodium fusidate | 16 | 375 | £62 | +189.7% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.